Effects of Lorazepam on Saccadic Eye Movements - Evidence from Prosaccade and Free Viewing Tasks

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2024 Sep 3

PMID 39225714

Authors

Philine M Baumert

Kaja Fassbender

Maximilian W M Wintergerst

Jan H Terheyden

Behrem Aslan

Tom Foulsham

Wolf Harmening

Ulrich Ettinger

Affiliations

Soon will be listed here.

Abstract

Rationale: Peak velocities of saccadic eye movements are reduced after benzodiazepine administration. Even though this is an established effect, past research has only examined it in horizontal prosaccade tasks.

Objectives: The spectrum of saccadic eye movements, however, is much larger. Therefore, we aimed to make a first attempt at filling this research gap by testing benzodiazepine effects on saccades under different experimental task conditions.

Methods: 1 mg lorazepam or placebo was administered (within-subjects, double-blind, in randomised order) to n = 30 healthy adults. Participants performed an extended version of the prosaccade task, including vertical saccade directions and different stimulus eccentricities, as well as a free viewing task.

Results: Results from the prosaccade task confirmed established effects of benzodiazepines as well as saccade direction on saccadic parameters but additionally showed that the drug effect on peak velocity was independent of saccade direction. Remarkably, in the free viewing task peak velocities as well as other saccade parameters were unaffected by lorazepam. Furthermore, exploration patterns during free viewing did not change under lorazepam.

Conclusions: Overall, our findings further consolidate the peak velocity of prosaccades as a biomarker of sedation. Additionally, we suggest that sedative effects of low doses of benzodiazepines may be compensated in tasks that more closely resemble natural eye movement behaviour, possibly due to the lack of time constraints or via neurophysiological processes related to volition.

References

Horn A . The reticular formation. Prog Brain Res. 2005; 151:127-55. DOI: 10.1016/S0079-6123(05)51005-7. View

Green J, King D, Trimble K . Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam. J Psychopharmacol. 2000; 14(1):30-6. DOI: 10.1177/026988110001400103. View

Knoflach F, Bertrand D . Pharmacological modulation of GABA receptors. Curr Opin Pharmacol. 2021; 59:3-10. DOI: 10.1016/j.coph.2021.04.003. View

Buttner-Ennever J . Mapping the oculomotor system. Prog Brain Res. 2008; 171:3-11. DOI: 10.1016/S0079-6123(08)00601-8. View

Dyckman K, Camchong J, Clementz B, McDowell J . An effect of context on saccade-related behavior and brain activity. Neuroimage. 2007; 36(3):774-84. DOI: 10.1016/j.neuroimage.2007.03.023. View

King W, Fuchs A . Reticular control of vertical saccadic eye movements by mesencephalic burst neurons. J Neurophysiol. 1979; 42(3):861-76. DOI: 10.1152/jn.1979.42.3.861. View

Muller H, Rabbitt P . Reflexive and voluntary orienting of visual attention: time course of activation and resistance to interruption. J Exp Psychol Hum Percept Perform. 1989; 15(2):315-30. DOI: 10.1037//0096-1523.15.2.315. View

Uusi-Oukari M, Korpi E . Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev. 2010; 62(1):97-135. DOI: 10.1124/pr.109.002063. View

Kummerer M, Wallis T, Bethge M . Information-theoretic model comparison unifies saliency metrics. Proc Natl Acad Sci U S A. 2015; 112(52):16054-9. PMC: 4702965. DOI: 10.1073/pnas.1510393112. View

10.

Muri R, Nyffeler T . Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS). Brain Cogn. 2008; 68(3):284-92. DOI: 10.1016/j.bandc.2008.08.018. View

11.

Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O . Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci. 1994; 244(1):49-51. DOI: 10.1007/BF02279812. View

12.

Itti L, Koch C . Computational modelling of visual attention. Nat Rev Neurosci. 2001; 2(3):194-203. DOI: 10.1038/35058500. View

13.

Clementz B, Gao Y, McDowell J, Moratti S, Keedy S, Sweeney J . Top-down control of visual sensory processing during an ocular motor response inhibition task. Psychophysiology. 2010; 47(6):1011-8. PMC: 2925050. DOI: 10.1111/j.1469-8986.2010.01026.x. View

14.

Bylinskii Z, Judd T, Oliva A, Torralba A, Durand F . What Do Different Evaluation Metrics Tell Us About Saliency Models?. IEEE Trans Pattern Anal Mach Intell. 2018; 41(3):740-757. DOI: 10.1109/TPAMI.2018.2815601. View

15.

von Wartburg R, Wurtz P, Pflugshaupt T, Nyffeler T, Luthi M, Muri R . Size matters: saccades during scene perception. Perception. 2007; 36(3):355-65. DOI: 10.1068/p5552. View

16.

Pierrot-Deseilligny C, Rivaud S, Gaymard B, Agid Y . Cortical control of reflexive visually-guided saccades. Brain. 1991; 114 ( Pt 3):1473-85. DOI: 10.1093/brain/114.3.1473. View

17.

ODriscoll G, Alpert N, Matthysse S, Levy D, Rauch S, Holzman P . Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography. Proc Natl Acad Sci U S A. 1995; 92(3):925-9. PMC: 42733. DOI: 10.1073/pnas.92.3.925. View

18.

Masson G, Mestre D, Martineau F, Soubrouillard C, Brefel C, Rascol O . Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors. Behav Brain Res. 2000; 108(2):169-80. DOI: 10.1016/s0166-4328(99)00152-7. View

19.

COLLEWIJN H, Erkelens C, Steinman R . Binocular co-ordination of human vertical saccadic eye movements. J Physiol. 1988; 404:183-97. PMC: 1190821. DOI: 10.1113/jphysiol.1988.sp017285. View

20.

Bey K, Lippold J, Aslan B, Hurlemann R, Ettinger U . Effects of lorazepam on prosaccades and saccadic adaptation. J Psychopharmacol. 2020; 35(1):91-99. DOI: 10.1177/0269881120972424. View